In the perspective of the role ACE2 plays in SARS‐CoV‐2 invasion and the likely impact of its depletion in the clinical manifestations of COVID‐19 disease, the observed additional changes in TMPRSS2 and ADAM17 tissue expression in experimental CHF may have pathophysiologic significance. Here, ACE2 is linked to congestive heart failure.